Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 737-743

  Mytar, B ^a   Siedlar, M ^a   Woloszyn M ^a   Ruggiero, I ^a   Pryjma, J ^b   Zembala, M ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cytotoxicity; Interactions; Monocyte; Reactive oxygen intermediates; Tumour cells

Indexed keywords

4 AMINOBENZOIC ACID DERIVATIVE; CATALASE; DEFEROXAMINE; DIMETHYL SULFOXIDE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MYELOPEROXIDASE; OXYGEN RADICAL; PHORBOL ESTER; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CHEMOLUMINESCENCE; CYTOTOXICITY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MONOCYTES; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TUMOR CELLS, CULTURED;

EID: 0033031295     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690118     Document Type: Article

References (39)

1. Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, Pfizenmaier K and Ronke M (1989) Regulation of tumour necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization. Proc Natl Acad Sci USA 86: 5064-5068
2. Davies B and Edwards SW (1992) Interactions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells. Br J Cancer 66: 463-469
3. Ding AH, Nathan CF and Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412
4. Ernst M, Lange A, Flad H-D, Havel A, Ennen J and Ulmer AJ (1984) Dissociation of responses measured by natural cytotoxicity and chemiluminescence. Eur J Immunol 14: 634-639
5. Galligioni E, Quaia M, Spada A, Favaro D, Santarosa M, Talamini R and Monfardini S (1993) Activation of cytolytic activity in peripheral blood monocytes of renal cancer patients against non-cultured autologous tumour cells. Int J Cancer 55: 380-385
6. Hara N, Ichinose Y, Asoh H, Yano T, Kawasaki M and Ohta M (1991) Superoxide anion - generating activity of polymorphonuclear leukocytes and monocytes in patients with lung cancer. Cancer 69: 1682-1687
7. Hasday JD, Shah EM and Lieberman AP (1990) Macrophage tumour necrosis factor alfa release is induced by contact with some tumors. J Immunol 145: 371-385
8. Hruby Z and Beck K-F (1997) Cytotoxic effect of autocrine and macrophage-derived nitric oxide on cultured rat mesangial cells. Clin Exp Immunol 107: 76-82
9. Ioannidis M and de Groot H (1993) Cytotoxicity of nitric oxide in Fu5 rat hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem J 296: 341-345
10. Jaattela M and Wissing D (1993) Heat-shock proteins protect cells from monocyte cytotoxicity - possible mechanism of sell protection. J Exp Med 177: 231-236
11. Jänicke R and Männel D (1990) Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J Immunol 144: 1144-1150
12. King CC, Jefferson MM and Thomas EL (1997) Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leukoc Biol 61: 293-302
13. Klassen DK and Sagone AL (1980) Evidence for both oxygen and non-oxygen dependent mechanisms of antibody sensitized target cell lysis by human monocytes. Blood 56: 985-993
14. Lanza F, Fietta A, Spisani S, Castoldi GL and Traniello S (1987) Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? J Clin Lab Immunol 22: 175-180
15. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629
16. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L (1992) The origin and function of tumour-associated macrophages. Immunol Today 13: 265-270
17. Martin JHJ and Edwards SW (1993) Changes in mechanisms of monocyte/ macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumour cell killing. J Immunol 150: 3476-3486
18. Mavier P and Edington TS (1984) Human monocyte-mediated tumour cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. J Immunol 132: 1980-1986
19. McLachlan JA, Serkin CD, Morrey KM and Bakouche O (1995) Antitumoral properties of aged human monocytes. J Immunol 154: 832-834
20. McNally JA and Bell AL (1996) Myeloperoxidase-based chemiluminescence of polymorphonuclear leukocytes and monocytes. J Biolumin Chemilumin II: 99-106
21. Nakabo Y and Pabst MJ (1997) C2-ceramide and C6-ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on killing of leukaemic cells by monocytes. Immunology 154: 477-482
22. Nathan CF and Cohn Z (1980) Role of oxygen-dependent mechanisms in antibody-induced lysis of tumour cells by activated macrophages. J Exp Med 152: 198-206
23. Nathan CF, Silverstein SC, Brukner L and Cohn ZA (1979) Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 149: 100-113
24. Palomba L, Sestili P, Cattabeni F, Azzi A and Cantoni O (1996) Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells. FEBS Lett 390: 91-94
25. Pazdrak K, Justement L and Alam R (1995) Mechanism of inhibition of eosinophil activation by transforming growth factor-b. J Immunol 155: 4454-4458
26. Pericle F, Sconocchia G, Titus JA and Segal DM (1996) CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol 157: 4657-4663
27. Pick E and Mizel D (1981) Rapid microassays for the measurements of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46: 211-226
28. Rothe G, Gabriel H, Kovacs E, Klucken J, Stöhr J, Kindermann W and Schmitz G (1996) Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arteriosclerosis Thromb Vascular Biol 16: 1437-1447
29. Siedlar M, Stachura J, Szczepanik A, Mattei M, Popiela T, Vendetti S, Colizzi V and Zembala M (1995) Characterization of human pancreatic carcinoma cell line with high metastatic potential in SCID mice. Invasion Metastasis 15: 60-69
30. Sun Y, Oberley LW, Elwell JH and Sierra-Rivera E (1989) Anti-oxidant enzyme activities in normal and transformed mouse liver cells. Int J Cancer 44: 1028-1033
31. Trulson A, Nilsson S and Venge P (1988) Lucigenin-enhanced chemiluminescence in blood is increased in cancer. Am J Clin Pathol 91: 441-445
32. Trulson A, Nilsson S, Brekkan E and Venge P (1994) Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence. Inflammation 18: 99-105
33. Utsugi T, Schroit AJ, Connor J, Bucana CD and Fidler IJ (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumour cells and recognition by activated human blood monocytes. Cancer Res 51: 3062-3066
34. Van Muijen GN, Danen EH, Veerkamp JH, Ruiter DJ, Lesley J and Van Den Heuvel LP (1995) Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 61: 241-248
35. Wong GH and Goeddel D (1989) Tumour necrosis factor. In Human Monocytes. Zembala M and Asherson GL (eds), pp. 195-215, Academic Press: London
36. Zembala M and Buckle AM (1989) Monocytes in malignant disease. In Human Monocytes. Zembala M and Asherson GL (eds), pp. 513-528, Academic Press: London
37. Zembala M, Czupryna A, Wieckiewicz J, Jasiński M, Pryjma J, Ruggiero I, Siedlar M and Popiela T (1993) Tumour cell induced production of tumour necrosis factor by monocytes of gastric patients receiving BCG immunotherapy. Cancer Immunol Immunother 36: 127-132
38. Zembala M, Siedlar M, Marcinkiewicz J and Pryjma J (1994a) Human monocytes are stimulated for nitric oxide release in vitro by some tumour cells but not by cytokines and lipopolysacharide. Eur J Immunol 24: 435-439
39. Zembala M, Siedlar M, Ruggiero I, Wieckiewicz J, Mytar B, Mattei M, Colizzi V (1994b) The MHC class II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56: 269-274